State of Alaska Department of Revenue Reduces Stock Position in Apollo Medical Holdings, Inc. (NASDAQ:AMEH)

State of Alaska Department of Revenue trimmed its stake in shares of Apollo Medical Holdings, Inc. (NASDAQ:AMEH – Get Rating) by 5.7% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 27,179 shares of the company’s stock after selling 1,653 shares during the period. State of Alaska Department of Revenue’s holdings in Apollo Medical were worth $1,059,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Nisa Investment Advisors LLC raised its stake in Apollo Medical by 285.7% during the 2nd quarter. Nisa Investment Advisors LLC now owns 810 shares of the company’s stock valued at $31,000 after buying an additional 600 shares during the last quarter. FMR LLC boosted its holdings in shares of Apollo Medical by 36.1% in the second quarter. FMR LLC now owns 1,067 shares of the company’s stock worth $41,000 after buying an additional 283 shares during the last quarter. Lazard Asset Management LLC bought a new stake in Apollo Medical during the first quarter valued at approximately $66,000. Quantbot Technologies LP purchased a new stake in Apollo Medical during the second quarter valued at approximately $54,000. Finally, PNC Financial Services Group Inc. boosted its stake in shares of Apollo Medical by 49.9% during the 1st quarter. PNC Financial Services Group Inc. now owns 1,563 shares of the company’s stock worth $75,000 after acquiring an additional 520 shares during the last quarter. Institutional investors own 34.91% of the company’s stock.

Apollo Medical Stock Performance

Shares of NASDAQ AMEH opened at $28.35 on Friday. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.84 and a quick ratio of 2.84. Apollo Medical Holdings, Inc. has a 1 year low of $26.89 and a 1 year high of $66.11. The firm has a fifty day moving average price of $30.70 and a 200-day moving average price of $38.54. The stock has a market cap of $1.61 billion, a PE ratio of 19.96 and a beta of 0.62.

Apollo Medical (NASDAQ:AMEH – Get Rating) last issued its quarterly earnings results on Thursday, November 3rd. The company reported $0.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.20 by $0.36. Apollo Medical had a return on equity of 13.49% and a net margin of 6.26%. The business had revenue of $317.00 million during the quarter, compared to analyst estimates of $269.60 million. Equities analysts anticipate that Apollo Medical Holdings, Inc. will post 1.2 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts recently commented on the company. Lake Street Capital started coverage on Apollo Medical in a report on Monday, December 19th. They issued a “buy” rating and a $40.00 target price on the stock. William Blair initiated coverage on Apollo Medical in a research note on Wednesday, September 21st. They issued an “outperform” rating on the stock. One equities research analyst has rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, Apollo Medical has a consensus rating of “Moderate Buy” and an average target price of $48.50.

Apollo Medical Profile

(Get Rating)

Apollo Medical Holdings, Inc, a physician-centric technology-powered healthcare company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.